Once-weekly injection of exenatide, sold in the U.S. as Bydureon, has been approved for use by the U.S. Food and Drug Administration. It’s main competitors are Byetta (exenatide injected twice daily) and Victoza (liraglutide). Byetta and Bydureon are made by the … Continue reading ![]()
